ESLAW

Conviction 14HealthcareScan · Thu, Jun 25, 2026

ESLAW$0.0000+0.00%

ResistanceSupportVol 14

Vol MA14 2.4K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

Estrella Immunopharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.estrellabio.com ↗

Price0.0000

Change+0.00%

Gap—

Rel volume0.00×

Avg volume3.24K

Avg $ vol380.89

SMA 200.0481

SMA 500.0557

SMA 2000.0401

Price vs 50-100.00%

Price vs 200-100.00%

MA stackmixed

50/200 cross—

Supertrendup · -0.0338

RSI (14)47

MACD hist-0.01

MACD crossbear · 4d

Stoch %K / %D0 / 0

ADX (14)6

+DI / −DI48 / 47

RSI divergence—

MACD divergence—

ATR %—

ADR %17.16%

52w high0.2357

52w low0.0000

From 52w high-100.00%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width493.24%

%B0.30

Donchian pos0.00%

Donchian high0.1425

Donchian low0.0000

AVWAP (52w high)0.0870

vs AVWAP high-100.00%

AVWAP (52w low)0.0694

vs AVWAP low-100.00%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d0.00×

Avg vol (14d)2.4K

Avg vol (20d)3.24K

Avg $ vol (20d)380.89

Market cap0

RS 3m (vs SPY)-112.26%

RS 6m (vs SPY)—

RS line new highNo

Trend template1/8

Technical rank—

1 week-100.00%

1 month-100.00%

3 months-100.00%

6 months—

1 year-100.00%

YTD—

P/E0.00

P/B0.00

P/S—

P/FCF—

EPS-0.3500

Div yield—

ROE247.87%

ROA-357.20%

Debt/Eq—

Current0.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-78.67%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.38M

Revenue—

Net income-2.29M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out2.21M

Employees—

ListedMon, Oct 2, 2023

Free float—

Float %—

Short interest26.31K

Days to cover6.5d

Short volume—

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank—

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.1425

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ESLAW

All disclosures →

No recent disclosed trades by Congress in ESLAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ESLAW

No recent insider (Form 4) filings in ESLAW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ESLAW

EDGAR →

No recent SEC filings on file for ESLAW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.